These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17980094)

  • 1. [Precursor lesions of type II endometrial cancer: diagnostic criteria and pathogenesis].
    Wang HJ; Zheng WX
    Zhonghua Bing Li Xue Za Zhi; 2007 Aug; 36(8):505-7. PubMed ID: 17980094
    [No Abstract]   [Full Text] [Related]  

  • 2. Five-year outcomes of adjuvant carboplatin/paclitaxel chemotherapy and intravaginal radiation for stage I-II papillary serous endometrial cancer.
    Kiess AP; Damast S; Makker V; Kollmeier MA; Gardner GJ; Aghajanian C; Abu-Rustum NR; Barakat RR; Alektiar KM
    Gynecol Oncol; 2012 Nov; 127(2):321-5. PubMed ID: 22850412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN).
    Goldberg H; Miller RC; Abdah-Bortnyak R; Steiner M; Yildiz F; Meirovitz A; Villà S; Poortmans PM; Azria D; Zidan J; Ozsahin M; Abacioglu U; Gold DG; Amit A; Lavie O; Atahan IL; Kuten A;
    Gynecol Oncol; 2008 Feb; 108(2):298-305. PubMed ID: 18096209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Chemotherapy and Radiotherapy on Management of Early Stage Clear Cell and Papillary Serous Carcinoma of the Uterus.
    Hong JC; Foote J; Broadwater G; Gaillard S; Havrilesky LJ; Chino JP
    Int J Gynecol Cancer; 2017 May; 27(4):720-729. PubMed ID: 28375927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation.
    Kelly MG; O'Malley D; Hui P; McAlpine J; Dziura J; Rutherford TJ; Azodi M; Chambers SK; Schwartz PE
    Gynecol Oncol; 2004 Dec; 95(3):469-73. PubMed ID: 15581948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serous EIC as an early form of uterine papillary serous carcinoma: recent progress in understanding its pathogenesis and current opinions regarding pathologic and clinical management.
    Zheng W; Schwartz PE
    Gynecol Oncol; 2005 Mar; 96(3):579-82. PubMed ID: 15721397
    [No Abstract]   [Full Text] [Related]  

  • 7. Prospective, non-randomized phase 2 clinical trial of carboplatin plus paclitaxel with sequential radical pelvic radiotherapy for uterine papillary serous carcinoma.
    Obermair A; Mileshkin L; Bolz K; Kondalsamy-Chennakesavan S; Cheuk R; Vasey P; Wyld D; Goh J; Nicklin JL; Perrin LC; Sykes P; Janda M
    Gynecol Oncol; 2011 Feb; 120(2):179-84. PubMed ID: 21126755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete response of a stage IV uterine papillary serous carcinoma to neoadjuvant chemotherapy with Taxol and carboplatin.
    Le TD; Yamada SD; Rutgers JL; DiSaia PJ
    Gynecol Oncol; 1999 Jun; 73(3):461-3. PubMed ID: 10366480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uterine papillary serous carcinoma: what have we learned over the past quarter century?
    Goff BA
    Gynecol Oncol; 2005 Sep; 98(3):341-3. PubMed ID: 16111527
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of treatment failures and survival of patients with uterine papillary serous carcinoma: a Cooperation Task Force (CTF) Study.
    Gadducci A; Cosio S; Landoni F; Maggino T; Zola P; Fuso L; Sartori E
    Int J Gynecol Cancer; 2012 Oct; 22(8):1355-60. PubMed ID: 22976496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trastuzumab with carboplatin/paclitaxel for treatment of advanced stage and recurrent uterine papillary serous carcinoma: A cost-effectiveness analysis.
    Batman S; Bohn J; Weisenberger MW; Hersh A; Bruegl A; Caughey A; Winter W
    Gynecol Oncol; 2021 Jan; 160(1):214-218. PubMed ID: 33393480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Uterine papillary serous carcinoma--a different kind of tumor].
    Steinman N; Avni A
    Harefuah; 1999 May; 136(10):810-2. PubMed ID: 10955120
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term survival in uterine clear cell carcinoma and uterine papillary serous carcinoma.
    Lindahl B; Persson J; Ranstam J; Willén R
    Anticancer Res; 2010 Sep; 30(9):3727-30. PubMed ID: 20944161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uterine papillary serous carcinoma: patterns of failure and survival.
    Wang W; DO V; Hogg R; Wain G; Brand A; Bull C; Stenlake A; Gebski V
    Aust N Z J Obstet Gynaecol; 2009 Aug; 49(4):419-25. PubMed ID: 19694700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathology of endometrial hyperplasia and endometrial carcinoma: an update.
    Horn LC; Meinel A; Handzel R; Einenkel J
    Ann Diagn Pathol; 2007 Aug; 11(4):297-311. PubMed ID: 17630117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An analysis of current treatment practice in uterine papillary serous and clear cell carcinoma at two high volume cancer centers.
    Vogel TJ; Knickerbocker A; Shah CA; Schiff MA; Isacson C; Garcia RL; Goff BA
    J Gynecol Oncol; 2015 Jan; 26(1):25-31. PubMed ID: 25376917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of conservatively treated endometrial complex atypical hyperplasia in a young woman: a case report.
    Corrado G; Baiocco E; Carosi M; Vizza E
    Fertil Steril; 2008 Nov; 90(5):2006.e5-8. PubMed ID: 18692828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clear cell and papillary serous endometrial carcinomas: survival in a series of 128 cases.
    Scarfone G; Secomandi R; Parazzini F; Viganò R; Mangili G; Frigerio L; Villa A; Tateo S; Ricci E; Bolis G
    Arch Gynecol Obstet; 2013 Feb; 287(2):351-6. PubMed ID: 23100038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Significance of Positive Pelvic Washings in Uterine Papillary Serous Carcinoma Confined to an Endometrial Polyp.
    Hanley KZ; Fadare O; Fisher KE; Atkins KA; Mosunjac MB
    Int J Gynecol Pathol; 2016 May; 35(3):249-55. PubMed ID: 26535985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of adjuvant therapy on survival of patients with early-stage uterine papillary serous carcinoma.
    Hamilton CA; Liou WS; Osann K; Berman ML; Husain A; Teng NN; Kapp DS; Chan JK
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):839-44. PubMed ID: 16199314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.